TradingView
RocketTickers
Nov 1, 2018 5:31 PM
AbbVie Announces Positive Results from CLL14
Long
NYSE:ABBV
1D
AbbVie Inc.
NYSE
Description
⋅
Nov 1, 2018 5:31 PM
ABBV: AbbVie
2018-10-31 16:14:00
AbbVie Announces Positive Results from CLL14, a Phase 3 Trial Evaluating a Venetoclax Combination as First-Line Therapy with a Fixed Duration of Treatment in Patients with Chronic Lymphocytic Leukemia
Beyond Technical Analysis
More